Clinical trial

A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About…

NCT00315367 · Neurognostics, Industry · Completed

Key facts

NCT number NCT00315367
Title A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties
Official title A Double-Blind, Crossover Trial of Aricept® in Memory-Impaired Patients With Multiple Sclerosis: A Phase IV Demonstration of Functional MRI (fMRI) as a Surrogate Marker of Brain Activity Associated With Improvement in Memory Function
Lead sponsor Neurognostics, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Relapsing-Remitting Multiple Sclerosis
Intervention type Drug
Interventions Donepezil HCI (drug)
Enrollment 26
Start date Sep 1, 2004
Completion Oct 1, 2007
First posted Apr 18, 2006
Last update posted Oct 16, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies